ICE-NYSE Deal Signals Major Change in Future of Trading
Posted on December 20, 2012 at 15:45 PM EST
Intercontinental Exchange (NYSE: ICE ) and NYSE Euronext (NYSE: NYX ) announced a deal before market open today (Thursday) by which ICE will acquire NYSE Euronext for $8.2 billion in cash and shares. News of an ICE-NYSE deal pushed NYX shares up 33% by afternoon trading, near the $33.12 bid price. The acquisition is subject to approval by regulators in the United States and Europe. This is ICE's second bite at the apple. A deal in which ICE and NASDAQ planned to take over NYX was scuttled last year by U.S. regulators who said that a combination between NYSE and NASDAQ OMX Group (NASDAQ: NDAQ ) would create an equity trading monopoly in the United States. Most analysts agree that the major rationale behind ICE's interest in NYSE Euronext is the latter's ownership of LIFFE, the leading European derivatives exchange. European regulators would have to approve the acquisition of LIFFE by ICE, which is a major electronic commodities and derivatives exchange in the U.S. "ICE is after Liffe, that is the crown jewel of NYSE Euronext," said Peter Lenardos, analyst at RBC Capital Markets in an interview with Reuters . "Strategically it makes sense for ICE to enter the European derivatives space in a meaningful way." Lenardos said that a combined entirety would be able to compete more effectively with the CME Group in both trading and clearing of OTC products. To continue reading, please click here...